Standardizing the Final Step of Regenerative Medicine Manufacturing

In cell therapy, stem cell applications, immune cell manufacturing, and regenerative medicine development, cell thawing is far more than a routine procedure—it is a critical control point that directly affects cell viability, functionality, and the consistency of clinical manufacturing processes. Although conventional 37°C water bath thawing remains widely used, it presents three major challenges for clinical-grade cell processing: the risk of waterborne contamination, operator-dependent variability, and the lack of comprehensive process documentation. As Taiwan's regenerative medicine regulations enter a new era of clinical implementation and manufacturing governance, hospitals, cell processing facilities, and CDMOs are facing increasing demand for standardized, traceable, and validated cell thawing workflows.

As the exclusive distributor of Lingan in Taiwan, Integrated Bio offers the Lingan Water-Free Multi-Well Cell Thawing System, which replaces traditional water bath thawing with an advanced dry heat conduction technology. This innovative design minimizes the risks of microbial and cross-contamination associated with water baths while providing synchronized multi-sample thawing, standardized operating procedures, temperature recording, user access control, and support for 3Q validation (IQ/OQ/PQ). These features help both research laboratories and clinical manufacturing facilities establish more reliable, compliant, and scalable cell recovery processes. The Lingan Water-Free Cell Thawing System is suitable for the recovery of stem cells, immune cells, PBMCs, T cells, NK cells, organoids, and other valuable biological samples. It is an ideal solution for regenerative medicine, cell therapy, clinical research, GMP manufacturing, and CDMO applications. More than an equipment supplier, Integrated Bio provides a comprehensive workflow solution covering cell cryopreservation, thawing and recovery, cell expansion, and clinical process implementation. We are committed to helping Taiwan's regenerative medicine industry establish safer, more reliable, and regulatory-compliant cell manufacturing platforms.